Safety and Efficacy of IONIS-FB-Lrx in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Not Recruiting
55 years - 99 years
All
Phase
3
10 participants needed
Brief description of study
The purpose of this study is to assess the Safety and Efficacy of IONIS-FB-Lrx patients with Geographic Atrophy secondary to Age Related Macular Degeneration
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Age-Related Macular Degeneration,AMD,Geographic Atrophy
-
Age: 55 years - 99 years
-
Gender: All
Male or Female. Over age 55, Well-demarcated Geographic Atrophy due to Age Related Macular Degeneration
Updated on
01 Aug 2024.
Study ID: 832840
